Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cuadrado

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Thrombosis and Haemostasis|December 29, 1999
Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndromeP M Dobado-Berrios, C López-Pedrera, F Velasco, et al.
Rheumatology (Oxford, England)|April 4, 2001
Chromium-51 ethylenediamine tetraacetic acid glomerular filtration rate: a better predictor than glomerular filtration rate calculated by the Cockcroft-Gault formula for renal involvement in systemic lupus erythematosus patientsT Godfrey, M J Cuadrado, C Fofi, et al.
Lupus|September 15, 1998
Prolactin levels in patients with systemic lupus erythematosus: a case controlled studyP Jimena, M A Aguirre, A López-Curbelo, et al.
The New England Journal of Medicine|April 13, 1995
The management of thrombosis in the antiphospholipid-antibody syndromeM A Khamashta, M J Cuadrado, F Mujic, et al.
Clinical and Experimental Rheumatology|November 17, 2020
The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomesKaren Schreiber, Massimo Radin, Irene Cecchi, et al.
Archives of Internal Medicine|May 22, 2002
Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5Guillermo Ruiz-Irastorza, Munther A Khamashta, Beverley J Hunt, et al.
Clinical and Molecular Allergy : CMA|July 19, 2016
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assaySavino Sciascia, Simone Baldovino, Karen Schreiber, et al.
International Journal of Cardiology|April 8, 2017
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarctionM Radin, K Schreiber, P Costanzo, et al.
The Journal of Rheumatology|May 8, 2003
Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodiesGiovanni Sanna, Maria L Bertolaccini, Maria J Cuadrado, et al.
Journal of Thrombosis and Haemostasis : JTH|September 14, 2006
Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndromeM J Cuadrado, P Buendía, F Velasco, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Thrombosis and Haemostasis|December 29, 1999
Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndromeP M Dobado-Berrios, C López-Pedrera, F Velasco, et al.
Rheumatology (Oxford, England)|April 4, 2001
Chromium-51 ethylenediamine tetraacetic acid glomerular filtration rate: a better predictor than glomerular filtration rate calculated by the Cockcroft-Gault formula for renal involvement in systemic lupus erythematosus patientsT Godfrey, M J Cuadrado, C Fofi, et al.
Lupus|September 15, 1998
Prolactin levels in patients with systemic lupus erythematosus: a case controlled studyP Jimena, M A Aguirre, A López-Curbelo, et al.
The New England Journal of Medicine|April 13, 1995
The management of thrombosis in the antiphospholipid-antibody syndromeM A Khamashta, M J Cuadrado, F Mujic, et al.
Clinical and Experimental Rheumatology|November 17, 2020
The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomesKaren Schreiber, Massimo Radin, Irene Cecchi, et al.
Archives of Internal Medicine|May 22, 2002
Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5Guillermo Ruiz-Irastorza, Munther A Khamashta, Beverley J Hunt, et al.
Clinical and Molecular Allergy : CMA|July 19, 2016
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assaySavino Sciascia, Simone Baldovino, Karen Schreiber, et al.
International Journal of Cardiology|April 8, 2017
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarctionM Radin, K Schreiber, P Costanzo, et al.
The Journal of Rheumatology|May 8, 2003
Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodiesGiovanni Sanna, Maria L Bertolaccini, Maria J Cuadrado, et al.
Journal of Thrombosis and Haemostasis : JTH|September 14, 2006
Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndromeM J Cuadrado, P Buendía, F Velasco, et al.
Pageof 8